Crystal (Cry) proteins made by the bacterium Bacillus thuringiensis are pore-forming toxins that specifically target insects and nematodes and are used around the world to kill insect pests. To better understand how pore-forming toxins interact with their host, we have screened for Caenorhabditis elegans mutants that resist Cry protein intoxication. We find that Cry toxin resistance involves the loss of two glycosyltransferase genes, bre-2 and bre-4. These glycosyltransferases function in the intestine to confer susceptibility to toxin. Furthermore, they are required for the interaction of active toxin with intestinal cells, suggesting they make an oligosaccharide receptor for toxin. Similarly, the bre-3 resistance gene is also required for toxin interaction with intestinal cells. Cloning of the bre-3 gene indicates it is the C. elegans homologue of the Drosophila egghead (egh) gene. This identification is striking given that the previously identified bre-5 has homology to Drosophila brainiac (brn) and that egh-brn likely function as consecutive glycosyltransferases in Drosophila epithelial cells. We find that, like in Drosophila, bre-3 and bre-5 act in a single pathway in C. elegans. bre-2 and bre-4 are also part of this pathway, thereby extending it. Consistent with its homology to brn, we demonstrate that C. elegans bre-5 rescues the Drosophila brn mutant and that BRE-5 encodes the dominant UDP-GlcNAc:Man GlcNAc transferase activity in C. elegans. Resistance to Cry toxins has uncovered a four component glycosylation pathway that is functionally conserved between nematodes and insects and that provides the basis of the dominant mechanism of resistance in C. elegans.
proteins from Bacillus thuringiensis. Of these, Cry proteins are unique in that they specifically target invertebrates (insects and nematodes) and are generally considered innocuous to mammals. Mammalian resistance to Cry toxins is thought to be due to toxin insolubility, lack of proper proteolytic processing, and lack of proper receptors in the mammalian gut (3) . As such, Cry proteins demonstrate a degree of safety toward vertebrates that is unmatched by any other pest control product and are used extensively around the world in the control of insect pests that damage crops and carry disease.
We previously reported on the isolation of Caenorhabditis elegans bre mutants (for Bt-toxin resistant) that resist Bt Cry protein intoxication (4) . When fed the main family crystal protein Cry5B either as protein crystals or as E. coli produced protein, C. elegans becomes rapidly sick and shows degeneration of the intestine, loss of coloration, inhibition of growth, inhibition of progeny production, and eventual death (4, 5) . Cry5B-resistant bre mutants were isolated among the F2 progeny of ethylmethanesulfonate mutagenized larvae. After screening 42,000 mutagenized haploid genomes for animals resistant to Cry5B, we isolated 14 alleles of bre-2, 19 alleles of bre-3, 9 alleles of bre-4, and 2 alleles of bre-5 (4). 2 All are strongly resistant to the pore-forming toxin, and all are healthy in the absence of toxin as well. To date we have also isolated one allele of bre-1 that has significantly weaker resistance to Cry5B (4) . No other loci have been identified in these screens. Thus, strong, healthy resistance to the pore-forming toxin inevitably leads to mutation of bre-2, bre-3, bre-4, or bre-5. The identification of bre-5 as a ␤1,3-glycosyltransferase gene has been reported (6) .
To our knowledge this approach is unique in its objective to genetically characterize how whole animals interact with and resist a bacterial pore-forming toxin. In the case of Cry proteins, identifying the genes that mutate to confer resistance is important since the major threat to the long term utility of insecticidal Cry proteins is the emergence of resistance. More generally, understanding the pathways that can mediate resistance might suggest therapeutic strategies for coping with bacterial toxins that target mammals.
Here, we identify the Cry5B toxin resistance genes bre-2 and bre-4 as glycosyltransferase genes that previously have not been genetically characterized. We find that bre-2 and bre-4 function in the intestine to confer susceptibility to Cry5B and are also required for the interaction of toxin with intestinal cells in vivo. We also identify the bre-3 resistance gene as sharing significant homology to Drosophila egghead (egh). Because bre-5 shares sequence similarity to the Drosophila brainiac (brn) gene and since egh and brn function in a single pathway in Drosophila, we hypothesized that the Cry protein intoxication pathway in C. elegans is equivalent to the Drosophila pathway. We indeed show that bre-3 and bre-5 function in a common pathway in C. elegans, that bre-2 and bre-4 are also part of this pathway, and that the C. elegans bre-5 gene has the same in vivo and in vitro activities as Drosophila brn.
EXPERIMENTAL PROCEDURES
C. elegans Culture and Microscopy-C. elegans was propagated using standard techniques with strain Bristol N2 as the wild type (7). All nematode assays were carried out at 20°C. For microscopy of live animals, nematodes were mounted on pads consisting of 2% agarose and 0.1% sodium azide. Low magnification microscopy was carried out on an Olympus BX-60 microscope using a 10ϫ objective coupled to a 0.5ϫ camera mount and a DVC camera. Endocytosis assays were imaged and deconvolved using a DeltaVision system (Applied Precision) on an Olympus IX-70 microscope using a 40ϫ objective (NA1.35) and differential interference contrast or fluorescence optics. Immunofluorescence images were captured on the DeltaVision system using a 40ϫ or 100ϫ objective (NA1.35) and differential interference contrast or fluorescence optics.
Cloning of bre Genes-bre-2(ye31) was placed in trans to dpy-18(e364) unc-64(e246). 25/25 Dpy nonUncs segregated bre-2(ye31), and 23/23 Unc nonDpys segregated bre(ϩ). The deficiency eDf2 also failed to complement bre-2(ye31), suggesting that bre-2 resided between unc-64 and the right breakpoint of eDf2. The bre-2(ye71) allele was generated by mutagenesis in the Hawaiian strain background (CB4856) and then placed in trans to unc-25(e156) bli-5(e518). Unc nonDpy and Dpy nonUnc recombinants were used to follow the segregation of single nucleotide polymorphisms, which indicated that bre-2 mapped between nucleotides 3,645 and 153,209 of Y39E4B. This region contains 14 predicted open reading frames (ORFs). Sequencing of cDNAs isolated from two bre-2 alleles indicated that both alleles contained point mutations in Y39E4B.9. Identification of the putative glycosyltransferase Y39E4B.9 as bre-2 was confirmed by reproducing the phenotype using RNA-mediated interference (data not shown) and by cDNA rescue from a bre-2 mutant. Analogous to bre-3 (below, including spliced leader 1 primer at the 5Ј end), a complete bre-2 cDNA was constructed using reverse-transcribed RNA from wild-type nematodes. The predicted amino acid sequence is exactly as predicted for Y39E4B.9.
bre-4(ye13) was placed in trans to unc-35(e259) dpy-5(e61). 29/32 Dpy nonUncs-segregated bre-4(ye13) indicated bre-4 was near and to the right of unc-35. Bre nonDpy recombinants from bre-4(ye13) dpy-5(e61)/ CB4856 heterozygotes placed bre-4 to the right of the single nucleotide polymorphism Y71G12B.60148. Dpy recombinants from heterozygotes unc-35(e259) dpy-5(e61),bre-4(ye43) (bre-4 allele in the Hawaiian background) placed bre-4 to the left of single nucleotide polymorphism Y92H12A.28829. The 150-kilobase region between these boundary single nucleotide polymorphisms contains 20 predicted ORFs. Sequencing of cDNA isolated from the bre-4 alleles revealed changes in the enzymatically characterized glycosyltransferase Y73E7A.7 (8) . cDNA rescue of a bre-4 mutant confirmed the identity of bre-4. A complete cDNA was assembled as for the other bre genes (including using spliced leader 1-specific primers). The predicted protein sequence corresponds exactly as predicted for ORF Y73E7A.7.
bre-3(ye28) was placed in trans to sma-2(e502) ced-7(n1892) unc-69(e587). Of 25 Sma non-Unc recombinants, 12 were sma-2(e502) bre-3(ye28) ced-7(ϩ), 12 were sma-2(e502) bre-3(ϩ) ced-7(n1892), and 1 was sma-2(e502) bre-3(ϩ) ced-7(ϩ). These data indicated bre-3 was close and to the left of ced-7. We co-injected bre-3(ye28) animals with cosmids in this region and plasmid pRF4, which encodes the dominant rol-6 marker, and found that 2/2 stably transmitting lines containing cosmid B0464 were rescued to toxin susceptibility. Subcloning and injection of different regions within B0464 indicated that the rescuing activity (8/8 lines) was conferred by a 4.3-kilobase FspI-NheI fragment containing nucleotides 13,437-17,729. This fragment contains a single predicted ORF B0464. 4 and an additional ϳ800 bases at both the 5Ј and 3Ј ends of the ORF. Sequencing of genomic DNA and cDNA from three bre-3 mutant alleles indicated these alleles contained alterations in this ORF, confirming the identity of the gene. A complete wild-type cDNA was assembled and sequenced from two overlapping fragments generated 1) at the 5Ј end by using random-primed total cDNA, a spliced leader 1 primer, an internal primer, and PCR and 2) at the 3Ј end by using a phage cDNA library (generously provided by Robert Barstead), a 3Ј end-specific vector primer, an internal primer, and PCR. The predicted protein sequence from this assemble cDNA corresponds exactly to that of the predicted B0464.4 ORF. Transmembrane domains in BRE-3 and other related proteins were predicted using TMHMM2.0.
Intestine-specific Expression and Rescue-pBluescript (KS) (Stratagene) was used as the vector backbone for test constructs. The cpr-1 promoter (9), corresponding to nucleotides 9,541-11,581 of cosmid C52E4, was amplified from C. elegans genomic DNA and cloned upstream of bre gene coding regions (for bre-2, bre-3, and bre-5, respectively, nucleotides 66,617-69,835 of Y39E4B, 14,285-16,925 of B0464, and 22,694 -23,958 of cosmid T12G3; the bre-4 coding region was amplified from C. elegans cDNA). Coding regions were fused in-frame to a double HA tag at their 3Ј ends, with a downstream transcription termination region derived from the bre-5 locus (T12G3 nucleotides 21,578 -22,699), except in the bre-3 construct, which contained the bre-3 transcription termination region downstream of the HA tag (B0464 nucleotides 13,437-14,287).
Constructs were co-injected with the dominant rol-6 marker (pRF4) into mutant animals to obtain stably transmitting lines carrying extrachromosomal arrays. Eggs laid by Roller (or N2 control) hermaphrodites were placed on modified ENG agar plates containing 1 mM isopropyl ␤-D-thiogalactoside and 50 g/ml carbenicillin and spread with E. coli cells expressing Cry5B (5) or with vector-only cells. Eggs were allowed to hatch and grow for 72 h, and resistance was scored based on the ability of larvae to progress to adulthood during the course of the experiment. For each construct tested at least two independent transgenic lines were assayed, and all lines possessed the reported phenotypes with Ͼ90% penetrance, with ϳ20 rollers and 20 non-rollers tested per line.
Fixation and Staining for Immunofluorescence Microscopy-The fixation procedure was a modification of that of Finney and Ruvkun (10) . A mixed population of a rescuing line expressing cpr-1::bre-5::2XHA or cpr-1::bre-3::2XHA was suspended in phosphate-buffered saline, 25% methanol, 3% formaldehyde and flash-frozen. After thawing under tap water worms were incubated on ice for 30 min followed by 2 washes in 50 mM sodium borate buffer, 0.01% Triton X-100, pH 9.5 (BO 3 T). Worms were then incubated for 20 min in BO 3 T plus 10 mM dithiothreitol followed by another wash in BO 3 T and a 20-min incubation in BO 3 T plus 0.3% hydrogen peroxide. Fixed and permeabilized worms were then washed in phosphate-buffered saline, 0.5% bovine serum albumin, 0.05% Triton X-100, 0.02% sodium azide (antibody buffer). For staining, all steps were carried out in antibody buffer using monoclonal anti-HA antibodies (16B12, Covance), and a final wash included 4Ј,6-diamidino-2-phenylindole for DNA staining.
Assays for Endocytosis of Rhodamine-labeled Cry5B-Cry5B protoxin was purified as described previously (6) and labeled using a 5-fold molar excess of NHS-rhodamine. Trypsinization was carried out at a 1:200 (trypsin:toxin) mass ratio for 2 h at 25°C. Trypsinized toxin was still toxic but 5-10-fold less based on growth assays. We used Edman degradation sequencing and determined that trypsin removes the first 170 amino acids, which includes predicted ␣ helix 3 but not helix 4. Consistent with our results studies with insecticidal Cry toxins show that ␣ helices 4 and 5 are critical for toxin function and that helices 1-3 may contribute some activity (11, 12) . Based on the apparent molecular weight of trypsinized toxin, trypsin is predicted to remove most of the carboxyl-terminal protoxin domain. Animals (L4 stage) were incubated in M9 medium containing 50 g/ml protoxin or 120 g/ml trypsinized toxin for 3 h and washed 3 times in M9 before imaging. For wash-out experiments, bre-4(ye13) and bre-5(ye17) animals fed rhodamine toxin for a few hours in wells were pipetted onto standard NG plates and examined every few minutes on an Olympus green fluorescent protein dissecting scope fitted with a rhodamine filter.
Single Mutant Versus Double Mutant Resistance Assays-All double mutants were constructed and confirmed using a similar strategy. For example, the bre-4(ye13),bre-5(ye17) double mutant was created by mating bre-4(ye13) males into the strain dpy-5(e61),bre-5(ye17) (bre-4 and dpy-5 are both on chromosome I). NonDpy F1 progeny were cloned, and in the F2 nonDpy Cry5B-resistant animals were picked that segregated F3 Dpy (bre-4(y13),dpy-5(e61),bre-5(ye17)). NonDpy F3 were cloned out, and those that did not segregate Dpy were selected as bre-4(ye13),bre-5(ye17) putative doubles. The presence of both mutations was verified by sequencing DNA.
To measure resistance of single and double mutants we used the Cry5B-related crystal protein Cry14A (5, 6). Cry14A is required for these studies since bre-2, -3, -4, and -5 are very highly resistant to Cry5B (e.g. they are not killed by even 1 mg/ml Cry5B) but are only moderately resistant to Cry14A. Cry14A was produced in E. coli and incorporated into the assay diet as described (6) . Assays were carried out in 24-well plates, with each well containing 400 l of S medium with 30 g/ml each of tetracycline and chloramphenicol and ϳ60 newly hatched L1 animals, with a final bacterial density of A 600 ϭ 0.25. After a 60-h exposure at 20°C, animals were mounted and imaged, and area measurements were made outlining the nematodes by hand and processing with NIH Image. bre-5 Rescue of the Drosophila brainiac Mutant-The bre-5 cDNA was cloned into pUAST (13) and used to transform yellow, white embryos using standard techniques. Two independent lines containing the transgene on chromosome II were used for brn complementation assays, which were carried out as described in Mü ller et al. (14) . Briefly, male UAS-bre-5 transformants were crossed to females of the genotype forked, brn 1.6P6 /FM6,w 1 , actin-, heat shock-or armadillo-GAL4,w ϩ . Rescue was scored based on the ability of forked male progeny to hatch. The GAL4 drivers used for this experiment carry the Bloomington stock numbers 1560 (armadillo-GAL4), 2077 (heat-shock GAL4), and 4414 (actin-GAL4). These lines were generously provided by Markus Noll and Erich Frei (Institute of Molecular Biology, University of Zü rich). Flies carrying UAS-brainiac and UAS-␤3GnT-IV (a human N-acetylglucosaminyltransferase) were used as positive and negative controls, respectively.
bre-5-dependent N-Acetylglucosaminyltransferase Assays-N2 and bre-5(ye17) mixed larval-staged animals were reared on ENG medium (standard NG with an additional 2.5 g of peptone and 1 g of yeast extract per liter), washed, flash-frozen in 50 mM Tris, pH 7.5, as a 0.2-ml pellet, and stored at Ϫ70°C. Samples were sonicated on ice in 0.05% Triton-X-100, 50 mM Tris and centrifuged at 15,000 ϫ g for 10 min to obtain a clarified supernatant. The assay mixture (25 l) contained 50 mM cacodylate, pH 6.5, 0.1% taurodeoxycholate, 10 mM MnCl 2 , 1 Ci of UDP- [6- 3 H]GlcNAc (39.7 Ci/mmol, PerkinElmer Life Sciences),10 mM Man␤1,4Glc-pNP (custom synthesis of Toronto Research, ON, Canada), and 8 g of extracted protein (N2 or bre-5) as the enzyme source. After incubation at 25°C for 7 h, the reaction products were diluted with 0.5 ml of 0.5 M NaCl and applied to a Sep-Pak C18 cartridge (100 mg; Waters). After washing the cartridge with 25 ml of water, the products were eluted with 50% methanol, dried, and counted by liquid scintillation.
RESULTS
To better understand how resistance to pore-forming Cry toxins develops, we used single-nucleotide polymorphisms to map the bre-2 and bre-4 genes to small molecular intervals of Յ20 genes, each of which contained a glycosyltransferase gene. Given that the previously identified bre-5 was shown to encode a glycosyltransferase gene (6), we sequenced cDNAs isolated from bre-2 and bre-4 mutant alleles and found that multiple alleles of each were associated with point mutations in the glycosyltransferase genes Y39E4B.9 and Y73E7A.7, respectively (Fig. 1, A and B) . At least one allele for each gene (bre-2(ye68) and bre-4(ye13)) is predicted to eliminate protein function by truncation of the putative glycosyltransferase catalytic domain, indicating that Cry5B resistance is the null phenotype for each. That RNA-mediated interference (RNAi) of bre-2 recapitulates Cry5B resistance supports this (data not shown). Rescue data (see below) confirm that these glycosyltransferase genes encode bre-2 and bre-4. Cloning and characterization of bre-3, which encodes an unusual glycosyltransferase of striking resemblance to a known glycosyltransferase in Drosophila, is dealt with below.
bre-2 encodes a putative family 31 ␤1,3-glycosyltransferase with a single amino-terminal membrane-spanning domain and an appropriately positioned DXD motif that is conserved in this enzyme family and is thought to be critical for catalysis (Fig.  1A) . In general, BRE-2 shares ϳ25% amino acid identity in its putative enzymatic domain with other ␤1,3-glycosyltransferases such as with BRE-5 (a ␤1,3-GlcNAc transferase; see Griffitts et al. (6) and below) and insect and mammalian ␤1,3-Gal and GlcNAc-transferases. bre-2 is also a member of a more closely related and expanded subfamily of C. elegans ␤1,3-glycosyltransferase genes that includes T09F5.1, F14B6.6, T09E11.10, E03H4.11, C54C8.3, F14B6.4, C47F8.3, C47F8.5, C47F8.6, and T15D6.5 and to which it shares ϳ40% identity in its glycosyltransferase domain. To our knowledge, bre-2 is the first one of these family members to be characterized genetically and to be demonstrated to have a loss of function phenotype.
bre-4 is predicted to encode a member of the family 7 glycosyltransferases, of which ␤1,4-galactosyltransferases are the best characterized (15) . BRE-4 is predicted to contain a single membrane-spanning region near its amino terminus as well as conserved residues involved in catalysis (Fig. 1B) . BRE-4 has been previously characterized biochemically as a UDPGalNAc:GlcNAc ␤1,4-N-acetylgalactosaminyltransferase (Ce␤4 GalNAcT) (8) . BRE-4/Ce␤4GalNAcT specifically synthesizes the GalNAc␤1,4GlcNAc sequence commonly found on glycoproteins and glycolipids. No mutational analysis of bre-4 has been previously reported. There are two other related glycosyltransferase genes in the C. elegans genome. Blast searches using both BRE-4 full-length protein and its enzymatic domain indicate a best hit and likely homologue in Drosophila melanogaster (predicted gene CG8536) and Anopheles gambiae (ORF from nucleotides 565443 to 566142, chromosome II). The predicted catalytic domains of these proteins, respectively, share 45 and 51% identity to the BRE-4 catalytic domain.
Expression of bre-5, bre-2, and bre-4 in the Intestine Is Required for Cry Protein Intoxication-Based on the fact that Cry toxins appear to specifically attack the gut cells of insects and nematodes, we predicted that bre-2 and bre-4 glycosyltransferase genes should be required in intestinal cells for Cry protein intoxication. To demonstrate this intestinal requirement while simultaneously confirming the correct identities of bre-2 and bre-4, we placed wild-type bre-2 genomic coding re- gion and bre-4 cDNA downstream of the intestinal-specific C. elegans promoter from the cpr-1 gene (9). As a control using the previously cloned bre-5 gene we also made a cpr-1::bre-5 construct in which a 2ϫ HA tag was fused in-frame at the carboxyl terminus of bre-5. Intestine-specific expression of the cpr-1 promoter was confirmed by HA antibody staining of a stably transmitting line transformed with the cpr-1::bre-5:HA construct (Fig. 2, A and B) . This construct was fully capable of restoring Cry5B susceptibility to a bre-5(ye17) mutant (Fig. 2,  C and D) , demonstrating that intestinal expression of wild-type bre-5 in an animal otherwise lacking bre-5 is sufficient for Cry protein intoxication and providing a complementary result to our mosaic experiments (6) .
We similarly found that intestinal-specific expression of wild-type bre-2 in a bre-2(ye31) mutant background and intestinal-specific expression of wild-type bre-4 in a bre-4(ye13) mutant background fully restored Cry toxin susceptibility to each (Fig. 2, E and F) . Thus, like bre-5, both glycosyltransferase genes act in the intestine in their mediation of Cry protein intoxication. The fact that the bre-2 gene complements a bre-2 mutant and that the bre-4 gene complements a bre-4 mutant also confirms the identities of these genes. To demonstrate specificity of rescue, we transformed a bre-5(ye17) mutant with the wild-type cpr-1::bre-2 construct that fully rescues a bre-2 mutant. No rescue of the bre-5 mutant by the bre-2 gene was seen (Fig. 2G) despite the fact that both are members of the extended ␤1,3-glycosyltransferase family.
Toxin Uptake in C. elegans Is Associated with Active Toxin and Requires bre-2, bre-4, and bre-3-We previously demonstrated that bre-5 is required for Cry5B toxin to interact with intestinal cells since bre-5(ye17) mutant animals fail to endocytose Cry5B protoxin labeled with rhodamine (6). However, because Cry proteins are produced as large (protoxin) precursors that are proteolytically activated, it was not demonstrated that toxin molecule taken up was the active toxin fragment or that the toxin had to be functional to be taken up. To extend these results, we fed C. elegans rhodamine-labeled Cry5B that was full-length (protoxin), proteolytically activated with trypsin (Fig. 3A) , or boiled to inactive it. As reported (6), full-length protoxin is readily taken up by intestinal cells into autofluorescent gut granules, which are reported to be the secondary lysosome (Fig. 3, B and C) . We found that trypsin-activated toxin is also endocytosed by intestinal cells (Fig. 3D ). In contrast, inactivated toxin is not taken up (Fig. 3E) . Thus, toxin uptake into intestinal cells is associated with activated, functional toxin.
In contrast to wild-type animals, bre-2(ye31) bre-4(ye13), and bre-3(ye28) (bre-3 is discussed further below), mutant animals do not endocytose either functional protoxin or trypsin-activated toxin into their intestinal cells (Fig. 3, F-K) . Rhodamine toxin seen in the intestinal lumen is not stably associated with the intestinal membrane since bre-4(ye13) and bre-5(ye15) mutant animals fed a pulse of rhodamine toxin flush the labeled toxin from their lumen within 5-10 min; no residual binding was detected (Fig. 3L, shown for bre-4(ye13) ). These results suggest that the glycosyltransferase genes make a component required for toxin to interact with the plasma membrane of the intestine. An alternative explanation, that these mutants are all defective in general endocytosis by the intestine is unlikely since all the mutants grow at relatively normal rates and have good brood production and because we have already demonstrated that bre-5(ye17) mutants are not obviously defective in endocytosis (6) .
bre-3 Encodes the C. elegans Homologue of Drosophila Egghead (egh)-Although the identities of bre-2 and bre-4
were not obviously linked to each other or bre-5 apart from the fact all are glycosyltransferase genes, the identification of bre-3 is striking given the identity of bre-5. bre-3 was cloned by genetic mapping followed by rescue with cosmid B0464 and then rescue with the single ORF B0464.4. bre-3 encodes a putative glycosyltransferase belonging to family 2 ␤ transferases (Fig. 4A) and includes aspartate residues conserved in this family. Many enzymes in this family, including BRE-3, also contain a characteristic QRXRW motif that is important for transferase function (16) . Based on sequencing mutant alleles, Cry5B resistance is the null phenotype for bre-3 since several known alleles (ye9 premature stop; ye28 internal deletion) are predicted to eliminate protein function. RNA-mediated interference of bre-3 recreated Cry5B resistance, confirming this conclusion. bre-3 mutant animals appear otherwise healthy.
BRE-3 has a very high level of sequence identity to Drosophila EGGHEAD (EGH) (60% amino acid identity over their entire lengths, Fig. 4A ). BRE-3 also is highly similar to a predicted EGH-like enzyme in A. gambiae (59% identity; Fig.  4A ). BRE-3 and EGH differ in length by only two amino acids at the very carboxyl terminus, and both are unique in their respective genomes.
EGH is known to specifically catalyze the transfer of mannose to glucose with a ␤1,4-glycosidic linkage (17) . BRE-3 and EGH also display low, but detectable, levels of sequence identity to processive glycosyltransferases from bacteria (e.g. NodC (Fig. 4A ) and cellulose synthase, not shown), suggesting that perhaps the invertebrate family evolved from the bacterial family. Consistent with this hypothesis, analysis of potential transmembrane regions for BRE-3, EGH, NodC, and other proteins of this class indicate striking conservation of structure not evident in sequence alignments. These enzymes are predicted to be anchored in the membrane at both the amino and carboxyl termini, with the enzymatic domain (amino acids 80 -330 for BRE-3) all predicted to sit in the cytosol (Fig. 4, B-D) .
BRE-3/EGH has no detectable amino acid sequence similarity to proteins from vertebrates.
We expressed 2ϫ HA-tagged BRE-3 under the control of the cpr-1 intestinal promoter and analyzed its localization in intestinal cells (Fig. 5A ). BRE-3::HA protein localizes to a punctate intracellular compartment. No detectable protein was seen at the plasma membrane. These results are consistent with BRE-3 acting as a glycosyltransferase that intracellularly modifies a Cry toxin receptor and not, despite the presence of multiple putative TM domains, as a direct receptor for Cry toxin at the plasma membrane. As with bre-2, bre-4, and bre-5, intestinal-specific expression of bre-3 was sufficient to restore susceptibility to toxin in a bre-3(ye28) mutant background (Fig.  5, B and C) .
The Four bre Glycosyltransferase Genes Function in a Single Pathway-The identity of the bre-3 gene as the C. elegans putative egh homologue is striking given the previous identification of bre-5 as having some sequence identity to Drosophila brainiac (brn). brn and egh display similar neurogenic phenotypes in Drosophila, act in the same genetic pathway in epithelial morphogenesis of Drosophila follicle cells, and have been shown to catalyze consecutive glycosylation reactions (14, (17) (18) (19) (20) . Based on enzymology, it is predicted that egh and brn function to synthesize Drosophila glycosphingolipids, although glycosphingolipid defects in the Drosophila mutants have yet to be shown. The similarities of bre-3 to egh and bre-5 to brn suggest that Cry protein intoxication in C. elegans uses the same pathway as that required for epithelial morphogenesis in Drosophila. To test whether bre-3 and bre-5 act in a common pathway for Cry5B intoxication, we examined the dose response of animals homozygous for the molecular null alleles bre-3(ye28), bre-5(ye17), and the double mutant bre-3(ye28),bre-5(ye17) to the Cry5B-related crystal toxin Cry14A (see "Experimental Procedures"). Each single and the double mutant shows a similar level of Cry toxin resistance (Fig. 6 ). These data indicate that, like egh and brn, bre-3 and bre-5 function in a single, common genetic pathway.
Given their similar phenotypes and identification as glycosyltransferase genes, we hypothesized that bre-2 and bre-4 also function in the same pathway as bre-3-bre-5. To test this hypothesis double mutants were made between bre-4(ye13) and each of the other mutants. The lesions in the alleles used are predicted to result in deletions of required catalytic residues, except bre-2(ye31), which results in a single amino acid change at a highly conserved residue. Resistance to Cry14A toxin was extensively quantitated in all single and double mutants at three doses (Fig. 7) . Resistance levels of each of the four single mutants are similar, and at any given dose, resistance levels of all double mutant strains were not statistically different (p Ն 0. (including bre-2; see above). To therefore test whether BRE-5 and BRN are true homologues, we drove expression of a wildtype copy of C. elegans bre-5 cDNA in Drosophila mutant for brn. Using three different promoters, we found that both brn and bre-5 could complement the lethality associated with Drosophila homozygous for the brn 1.6P6 (21) mutation (Table I) . In contrast, a human ␤1,3-N-acetylglucosaminyltransferase was not able to rescue brn lethality. Thus, BRE-5 is the C. elegans homologue of Drosophila BRN.
The functional homology of bre-5 and brn predicts that bre-5 should encode N-acetylglucosaminyltransferase (GlcNAc-transferase) activity. Enzymatic experiments performed with extracts from wild-type animals demonstrate that C. elegans has GlcNAc-transferase activity when Man␤1,4Glc-pNP is used as the acceptor (the preferred acceptor for BRN) (Fig. 8) . This activity returns almost to background levels when extracts are prepared from bre-5(ye17) homozygous animals instead of wild type (Fig. 8) . These data indicate that BRE-5 is a UDP-GlcNAc:Man N-acetylglucosaminyltransferase and that BRE-5 provides the majority of such activity in C. elegans. Given the lack of a vertebrate bre-3/egh homologue, the functional conservation of bre-5 and brn, and the fact that bre-5 and brn are more similar to each other than they are to mammalian ␤1,3-glycosyltransferases, it appears that the bre-3/egh-bre-5/ brn pathway is an invertebrate-specific glycosylation pathway. Enzymatically, egh and brn catalyze consecutive steps that are consistent with the production of glycosphingolipids, although this has yet to be demonstrated in vivo. Our identification of two additional genes, bre-2 and bre-4, extends this pathway. The bre-4 gene product has been previously demonstrated to have glycosyltransferase activity (8) ; the bre-2 gene product has not, and thus, BRE-2 should be regarded as a putative glycosyltransferase. A likely bre-4 homologue in Drosophila is noted above.
All four bre mutants are defective in the uptake of toxin into intestinal cells. Furthermore, chase experiments in live animals indicate that toxin is not significantly associated with intestinal membranes in bre-4 or bre-5 mutant animals. These data suggest that the bre genes are involved in promoting the interaction of Cry5B and Cry14A crystal toxins with the intestinal plasma membrane. The simplest interpretation of these data is that the bre genes synthesize an oligosaccharide that is transported to the apical membrane of the intestine that serves as a receptor for crystal toxins (Fig. 9) . Ample precedent exists for bacterial toxins binding to extracellular carbohydrates including aerolysin, cholera toxin, and Shiga toxin. Because loss of any of the bre enzymes leads to high levels of resistance to Cry5B, we hypothesize that this receptor is the major receptor for Cry5B. In the case of Cry14A, the reduced level of resistance conferred by the mutants suggests that other receptors can partly compensate in the absence of the bre oligosaccharide (Fig. 9 ). An alternative interpretation of our data is that the bre genes do not make a direct receptor for toxin but, rather, influence the membrane or membrane proteins in a way that promotes toxin binding and/or uptake.
This work reiterates and provides striking in vivo genetic evidence for the importance of carbohydrates in the interaction of bacterial toxins with their host. Our screen for healthy, robust resistant mutants did not uncover any mechanisms of resistance other than the bre glycosylation pathway. Given the number of alleles we isolated for each of these genes, it is likely that the list of strong, healthy Cry5B resistance genes is complete or nearly complete. Our data also suggest that receptor binding of a bacterial pore-forming toxin is a central target for potential therapeutics. For example, the modulation of carbohydrates (e.g. using synthetic carbohydrates as competitive inhibitors) could have therapeutic benefits against bacterial toxins that require carbohydrates for interacting with the host. Such a strategy is being explored with Shiga toxin in mammals (22) .
Our results have important implications for the biology of Cry toxins and Cry toxin resistance as well. The identification of bre-2, bre-3, and bre-4 doubles the number of Cry toxin resistance genes known. That the bre genes mutate to resistance for two divergent crystal proteins, Cry5B and Cry14A (ϳ34% identical at the amino acid level) suggests that they will be relevant to the biology of other Cry toxins as well. Significantly, Cry14A has been reported to be toxic to coleopteran insects (23) , suggesting that insects could use the same receptor. In addition, some insect resistance to Cry toxin has been has been correlated with changes in complex carbohydrate structures (24, 25) . Along with the striking conservation of the bre-3-bre-5 pathway with the egh-brn pathway in insects, these observations suggest our results may be relevant to Cry toxin resistance in insects as well. Unlike the C. elegans bre mutants, Drosophila mutants in this pathway are often lethal. Thus insects may be less able to tolerate loss of function of this pathway. Perhaps this is part of the reason for the high efficacy of insecticidal Cry toxins even over long periods of selection (26) . However, viable/sterile mutant alleles of egh and brn exist. It is, therefore, possible that mutations in these could contribute to the development of resistance in insects. This contribution could be investigated by analysis of homologous sequences in resistant insects and could provide vital information about how invertebrate pests and disease vectors evolve resistance to Cry toxins and how the emergence of resistance can be minimized. provided by the C. elegans Genetics Center (funded by the National Institutes of Health National Center for Research Resources).
